Comparison of Anti-mutated Citrullinated Vimentin with Anti-cyclic Citrullinated Peptide and Rheumatoid Factors for the Diagnostic Value of Rheumatoid Arthritis
Authors:
Open Access
- 1 January 2007
- journal article
- Published by Korean College of Rheumatology in The Journal of the Korean Rheumatism Association
- Vol. 14 (3) , 235-241
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritisArthritis Research & Therapy, 2006
- Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)Annals of the Rheumatic Diseases, 2004
- Treating rheumatoid arthritis early: A window of opportunity?Arthritis & Rheumatism, 2002
- The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptideArthritis & Rheumatism, 2000
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.Journal of Clinical Investigation, 1998
- The Effectiveness of Early Treatment with “Second-Line” Antirheumatic DrugsAnnals of Internal Medicine, 1996
- AUTOANTIBODY TO THE NUCLEAR ANTIGEN RA33: A MARKER FOR EARLY RHEUMATOID ARTHRITISRheumatology, 1993
- Demonstration of a new antinuclear antibody (ANTI‐RA33) that is highly specific for rheumatoid arthritisArthritis & Rheumatism, 1989
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Anti-keratin antibodies in rheumatoid arthritis.BMJ, 1979